Cardiovascular Drugs Practice Questions

Q: Drugs acting on K+ channels include which of the following?

Nicorandil. ***Nicorandil*** - **Nicorandil** is a **potassium channel activator** that causes vasodilation by opening ATP-sensitive potassium channels in vascular smooth muscle cells. - This action leads to hyperpolarization of the cell membrane, making it more difficult for calcium influx and thus promoting relaxation and **vasodilation**. *Spironolactone* - **Spironolactone** is an **aldosterone antagonist** that works by blocking aldosterone receptors in the renal collecting tubules. - Its main effect is to increase sodium and water excretion while **conserving potassium**, making it a potassium-sparing diuretic, but it does not directly act on potassium channels for its primary mechanism. *Amiloride* - **Amiloride** is a **potassium-sparing diuretic** that directly inhibits **epithelial sodium channels (ENaC)** in the collecting duct. - By blocking sodium reabsorption, it indirectly reduces potassium secretion, thus conserving potassium, but it does not directly affect potassium channels. *Methyldopa* - **Methyldopa** is a **centrally acting alpha-2 adrenergic agonist** that reduces sympathetic outflow from the central nervous system. - It decreases peripheral vascular resistance and heart rate, leading to a reduction in blood pressure, and does not directly interact with potassium channels.

Q: Which drug is most classically associated with QT interval prolongation?

Quinidine. ***Quinidine*** - **Quinidine** is a Class IA antiarrhythmic drug that is the **classic textbook example** of drug-induced QT interval prolongation. - It blocks **sodium channels** and **potassium channels**, specifically delayed rectifier potassium channels (IKr). - This blockade of potassium channels **slows repolarization** of the cardiac myocyte, thereby prolonging the **QT interval** and increasing the risk of **Torsades de Pointes**. - Historically, quinidine has been the **prototype drug** used to teach this adverse effect in medical education. *Magnesium Sulfate* - **Magnesium sulfate** is used to **treat Torsades de Pointes**, a polymorphic ventricular tachycardia often associated with **QT prolongation**, but it does not primarily cause QT prolongation itself. - Its mechanism involves stabilizing the cardiac membrane and reducing abnormal electrical activity, rather than lengthening the **QT interval**. *Lignocaine* - **Lignocaine** (Lidocaine) is a Class IB antiarrhythmic drug that primarily blocks **sodium channels**, shortening the action potential duration in some cardiac tissues. - It does **not** significantly prolong the **QT interval**; in some cases, it can even shorten it, making it safer in patients with pre-existing QT prolongation. *Amiodarone* - **Amiodarone** is a Class III antiarrhythmic drug that blocks multiple channels, including **potassium channels**, leading to significant **QT interval prolongation**. - While amiodarone does prolong the QT interval considerably, the question asks for the **"most classically associated"** drug, which is quinidine—the historical prototype for this adverse effect. - The associated risk of **Torsades de Pointes** with amiodarone is lower than with Class IA agents like quinidine due to its **less proarrhythmic** profile, making quinidine the more classic teaching example.

Q: Which of the following medications is primarily used to decrease serum triglycerides?

Fibrates. ***Fibrates*** - Fibrates, such as **gemfibrozil** and **fenofibrate**, are primarily used to activate **PPAR-alpha**, leading to increased lipoprotein lipase activity and reduced hepatic triglyceride synthesis. - This effectively lowers **serum triglyceride levels** by 20-50% and can also increase HDL cholesterol. *Statin* - Statins primarily inhibit **HMG-CoA reductase**, the rate-limiting enzyme in cholesterol synthesis, which makes them highly effective at lowering **LDL cholesterol**. - While they can cause a modest reduction in triglycerides (10-30%), this is not their primary mechanism or indication. *Ezetimibe* - Ezetimibe works by inhibiting the absorption of **cholesterol** at the brush border of the small intestine, thereby lowering **LDL cholesterol**. - It has minimal effect on **triglyceride levels** and is not indicated for primary triglyceride reduction. *Niacin* - Niacin, or **nicotinic acid**, reduces the liver's production of VLDL (which contains triglycerides) and LDL, and also increases HDL cholesterol. - While it can significantly lower triglycerides, its use is often limited by bothersome side effects such as **flushing** and itchiness, making fibrates generally preferred for primary triglyceride lowering due to better tolerability.

Q: Digitalis is used in mitral stenosis to control the ventricular rate when the patient develops which condition?

Atrial fibrillation. ***Atrial fibrillation*** - **Digitalis** (digoxin) is effective in **slowing the ventricular rate** in atrial fibrillation by increasing vagal tone and prolonging the refractory period of the AV node. - In **mitral stenosis**, an uncontrolled rapid ventricular rate due to atrial fibrillation can significantly reduce cardiac output and worsen symptoms. *Right ventricular failure* - While digitalis can improve contractility, its primary role in **RV failure** is not rate control; diuretics and afterload reduction are more commonly used. - A patient with isolated right ventricular failure due to mitral stenosis would not directly benefit from digitalis for rate control. *Acute pulmonary edema* - **Acute pulmonary edema** requires rapid diuresis, oxygen, and vasodilators to reduce preload and afterload. - Digitalis has a slower onset of action and is not the first-line treatment for acute pulmonary edema, especially if the cause is not related to a rapid ventricular rate. *Myocarditis* - **Myocarditis** is an inflammation of the heart muscle, and digitalis is generally avoided due to concerns about potentially worsening arrhythmias and myocardial damage in an inflamed heart. - Treatment for myocarditis focuses on supportive care and addressing the underlying cause, not rate control with digitalis unless specific arrhythmias develop.

Q: Fenoldopam is used in the management of?

Hypertensive emergencies. ***Hypertensive emergencies*** - **Fenoldopam** is a **dopamine D1 receptor agonist** that causes rapid, dose-dependent peripheral vasodilation and increased renal blood flow, making it suitable for acute blood pressure reduction during hypertensive emergencies. - Its **rapid onset** and short half-life allow for precise control of blood pressure, and its **benefit** in preserving or improving renal function is particularly beneficial in patients with renal impairment. *Congestive heart failure* - While fenoldopam can increase renal blood flow, it is not a primary treatment for **congestive heart failure (CHF)** and is not typically used for its management. - Other drug classes, such as **diuretics**, **ACE inhibitors**, and **beta-blockers**, are the mainstays of CHF treatment. *Migraine prophylaxis* - Fenoldopam has **no role** in the prevention or acute treatment of migraines. - **Beta-blockers**, **calcium channel blockers**, and certain **antidepressants** are commonly used for migraine prophylaxis. *Tachyarrhythmias* - Fenoldopam **does not have antiarrhythmic properties** and is not indicated for the treatment of tachyarrhythmias. - **Beta-blockers**, **calcium channel blockers**, and specific **antiarrhythmic drugs** are used to manage tachyarrhythmias.

Q: Which class of antihypertensive drugs is known to cause erectile dysfunction?

Beta-blockers. ***Beta-blockers*** - **Beta-blockers** are the antihypertensive class most commonly associated with **erectile dysfunction** - Mechanism: Reduced cardiac output, decreased peripheral blood flow, central nervous system effects reducing libido, and blockade of β2-mediated vasodilation - **Non-selective beta-blockers** (propranolol, nadolol) have higher incidence of ED compared to selective β1-blockers (metoprolol, atenolol) - Newer vasodilating beta-blockers (nebivolol, carvedilol) have lower risk of sexual dysfunction *Calcium channel blockers* - Generally have **neutral or minimal effect** on erectile function - May even improve ED in some patients due to **vasodilatory properties** - Side effects include peripheral edema and headache, but not sexual dysfunction *ACE inhibitors* - Associated with **lower risk of erectile dysfunction** compared to other antihypertensives - May have neutral or even protective effects on sexual function - Preferred choice for hypertensive patients with existing sexual dysfunction concerns - Common side effects: dry cough and angioedema (not related to sexual function) *AT1 receptor antagonists* - **ARBs have neutral to potentially beneficial effects** on sexual function - Considered an excellent alternative for patients experiencing sexual side effects with other antihypertensive medications - Some studies suggest they may improve erectile function in hypertensive patients

Q: Which of the following adverse effects of ACE inhibitors is primarily due to the inhibition of aldosterone secretion?

Hyperkalemia. ***Hyperkalemia*** - **Angiotensin II** stimulates aldosterone secretion, and **ACE inhibitors** block angiotensin II formation, leading to reduced aldosterone. - **Aldosterone** promotes sodium reabsorption and potassium excretion in the renal tubules, so its reduction causes **potassium retention** and **hyperkalemia**. - This is the primary adverse effect mediated through the **aldosterone pathway**. *Respiratory tract irritation* - This is primarily due to the accumulation of **bradykinin** and **substance P** in the airways, not due to the inhibition of aldosterone. - ACE is responsible for bradykinin breakdown, so its inhibition leads to **bradykinin accumulation** causing cough. *Facial swelling* - This is a symptom of **angioedema**, which is related to the accumulation of **bradykinin** due to ACE inhibition, not due to aldosterone inhibition. - Bradykinin causes **vasodilation** and increased vascular permeability. *Hypotension* - While hypotension can occur with ACE inhibitors, it is primarily due to reduced formation of the potent vasoconstrictor **angiotensin II**, causing **decreased systemic vascular resistance**. - This is NOT primarily mediated through the aldosterone pathway, but through direct vascular effects.

Q: Which non-selective beta-blocker has sympathomimetic activity?

Pindolol. ***Pindolol*** - **Pindolol** is a **non-selective beta-blocker** that exhibits **intrinsic sympathomimetic activity (ISA)**, meaning it acts as a partial agonist at beta-adrenergic receptors. - Due to ISA, it causes less reduction in resting heart rate and cardiac output compared to beta-blockers without ISA. *Acebutalol* - **Acebutalol** is a **beta-1 selective blocker** (cardioselective) that possesses **intrinsic sympathomimetic activity (ISA)**. - While it has ISA, it is not a non-selective beta-blocker, making it an incorrect answer for this question. *Nadolol* - **Nadolol** is a **non-selective beta-blocker** that does **not** have intrinsic sympathomimetic activity (ISA). - It primarily acts as a pure antagonist at both beta-1 and beta-2 adrenergic receptors. *Metoprolol* - **Metoprolol** is a **beta-1 selective blocker** (cardioselective) and does **not** possess intrinsic sympathomimetic activity (ISA). - Its primary action is blockade of cardiac beta-1 receptors.

Q: Which of the following is non-selective 3rd generation Beta blocker ?

Carvedilol. ***Carvedilol*** - **Carvedilol** is a **non-selective beta-adrenergic antagonist** (blocks both β1 and β2 receptors) with **additional α1-adrenergic blocking activity**, making it a true **3rd generation beta-blocker**. - The α1-blockade provides **vasodilatory properties**, reducing peripheral vascular resistance and improving hemodynamics. - It has favorable effects on lipid metabolism and insulin sensitivity, making it particularly useful in heart failure and hypertension. - Its non-selective beta-blockade combined with vasodilation distinguishes it from selective 3rd generation agents. *Betaxolol* - **Betaxolol** is a **selective β1-adrenergic antagonist** without vasodilatory properties. - Classified as a **2nd generation beta-blocker** due to its cardioselectivity. - Primarily used in glaucoma and hypertension but lacks the non-selective profile and additional mechanisms of 3rd generation agents. *Celiprolol* - **Celiprolol** is a **β1-selective antagonist** with **β2-agonistic effects** providing vasodilation. - While classified as 3rd generation due to vasodilatory properties, it is **selective for β1**, not non-selective. - Its β2-agonism causes peripheral vasodilation but maintains β1-selectivity. *Nebivolol* - **Nebivolol** is a highly **selective β1-adrenergic antagonist** with **vasodilatory effects via nitric oxide (NO) release**. - Classified as 3rd generation due to NO-mediated vasodilation, but it is **β1-selective**, not non-selective. - The combination of high β1-selectivity and endothelial-mediated vasodilation makes it unique among 3rd generation agents.

Q: Which of the following is a lipid insoluble beta-blocker?

Celiprolol. ***Celiprolol*** - **Celiprolol** is a **hydrophilic** (lipid-insoluble) beta-blocker, meaning it has low lipid solubility and does not readily cross the blood-brain barrier. - This property reduces the likelihood of **CNS side effects** such as nightmares and insomnia. *Timolol* - **Timolol** is a **lipophilic** (lipid-soluble) beta-blocker, allowing it to penetrate the central nervous system. - Its high lipid solubility contributes to a higher incidence of **CNS side effects**. *Carvedilol* - **Carvedilol** is a **lipophilic** mixed alpha and beta-blocker, which means it can cross the blood-brain barrier. - This can lead to central nervous system effects, although its primary clinical use is in heart failure and hypertension. *Pindolol* - **Pindolol** is a **lipophilic** beta-blocker with intrinsic sympathomimetic activity (ISA). - Its lipid solubility allows it to enter the brain, potentially causing **CNS-related side effects**.

Question 1

Drugs acting on K+ channels include which of the following?

Accepted Answer

Nicorandil

Answer

Methyldopa

Answer

Amiloride

Answer

Spironolactone

Question 2

Which drug is most classically associated with QT interval prolongation?

Accepted Answer

Quinidine

Answer

Magnesium Sulfate

Answer

Lignocaine

Answer

Amiodarone

Question 3

Which of the following medications is primarily used to decrease serum triglycerides?

Accepted Answer

Fibrates

Answer

Ezetimibe

Answer

Niacin

Answer

Statin

Question 4

Digitalis is used in mitral stenosis to control the ventricular rate when the patient develops which condition?

Accepted Answer

Atrial fibrillation

Answer

Right ventricular failure

Answer

Acute pulmonary edema

Answer

Myocarditis

Question 5

Fenoldopam is used in the management of?

Accepted Answer

Hypertensive emergencies

Answer

Congestive heart failure

Answer

Migraine prophylaxis

Answer

Tachyarrhythmias

Question 6

Which class of antihypertensive drugs is known to cause erectile dysfunction?

Accepted Answer

Beta-blockers

Answer

Calcium channel blocker

Answer

ACE inhibitors

Answer

AT1 receptor antagonists

Question 7

Which of the following adverse effects of ACE inhibitors is primarily due to the inhibition of aldosterone secretion?

Accepted Answer

Hyperkalemia

Answer

Respiratory tract irritation

Answer

Facial swelling

Answer

Hypotension

Question 8

Which non-selective beta-blocker has sympathomimetic activity?

Accepted Answer

Pindolol

Answer

Nadolol

Answer

Acebutalol

Answer

Metoprolol

Question 9

Which of the following is non-selective 3rd generation Beta blocker ?

Accepted Answer

Carvedilol

Answer

Betaxolol

Answer

Celiprolol

Answer

Nebivolol

Question 10

Which of the following is a lipid insoluble beta-blocker?

Accepted Answer

Celiprolol

Answer

Timolol

Answer

Carvedilol

Answer

Pindolol

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?